Hypoxia (low O2) plays a central role in a diverse array of human diseases. O2 is sensed by the hypoxia response pathway comprising a prolyl hydroxylase (PHD) enzyme, which uses O2 to hydroxylate specific prolines on the Hypoxia Inducible Factor ? (HIF?). Once hydroxylated, HIF? is ubiquitinated by the Von Hippel-Lindau (VHL) ubiquitin ligase, resulting in its proteolysis. When hypoxia ensues, PHD enzymes lack the O2 to hydroxylate HIF?, resulting in HIF? stabilization, entry into the nucleus, and the transcriptional regulation of multiple target genes. We currently do not know all of the proteins that regulate this pathway, how this pathway is modulated in different tissue types, or how it uses a single O2 sensor with a low affinity for O2 to respond to a broad dynamic range of O2 concentration. Because of the essential requirement of pathway components in early development and viability in mammals, we also know little about how the pathway actually works in vivo in an intact animal. To address these questions, this proposal takes advantage of genetics and an intact, isogenic model organism (C. elegans) that can thrive under hypoxia and whose environment and genetics can be controlled with fidelity and reproducibility. C. elegans possess single genes for the PHD (EGL-9), the VHL (VHL-1), and the HIF? (HIF-1). We recently identified four new regulators/mediators of this pathway. First, the PMK-1 ortholog of p38 MAPK promotes EGL-9 function under normoxia. Second, the EGL-4 ortholog of Protein Kinase G (PKG) is a substrate of PMK-1 that is required for PMK-1 to regulate EGL-9 activity. Third, the PDR- 1 ortholog of the ubiquitin ligase Parkin inhibits HIF-1 in neurons. Fourth, the CHN-1 ortholog of the ubiquitin ligase and chaperone CHIP, a factor known to work with Parkin, inhibits HIF-1 in neurons. We hypothesize that PMK-1 regulates the pathway by activating EGL-4 via phosphorylation. We believe that they allow for an additional layer of regulation, expanding the dynamic range of O2 sensation and modulating the timing of the response. We also hypothesize that PDR-1 and CHN-1 form an ubiquitin ligase pair that regulates HIF-1 independently of (and in different tissues from) regulation by VHL-1, thereby allowing context-specific and tissue-specific patterns of hypoxia response. Here we will characterize the mechanism by which CHN-1, PDR-1, EGL-4, and PMK-1 regulate the pathway in vivo. We will measure HIF-1 ubiquitination and turnover, target gene expression, EGL-9 activity and subcellular localization, hypoxia survival, O2 consumption and ATP generation, oxidative stress, and mitochondrial dynamics in mutants for these factors. We will directly test whether PDR-1 and CHN-1 regulate the pathway through HIF-1. We will test whether PMK-1 regulates the pathway by phosphorylating EGL-4. We will use a proteomics approach to identify downstream substrates of EGL-4 that operate as part of the pathway. At its conclusion, these studies will have provided the foundation for examining whether the orthologs of these factors conduct similar roles in mammals.

Public Health Relevance

Hypoxia (O2 deprivation) plays a central role in a diverse array of human diseases, including ischemic stroke, myocardial infarction, traumatic brain injury, spinal cord injury, pulmonary hypertension, Cerebral Palsy, and cancer. Metazoans respond to hypoxia by employing a conserved hypoxia response pathway. It is critical to identify all of the components of this pathway and to understand how this pathway operates in response to hypoxia in order to develop novel applications for the treatment and prevention of disorders and diseases that involve hypoxia as part of their etiology.

National Institute of Health (NIH)
National Institute of General Medical Sciences (NIGMS)
Research Project (R01)
Project #
Application #
Study Section
Neural Oxidative Metabolism and Death Study Section (NOMD)
Program Officer
Gaillard, Shawn R
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Rutgers University
Organized Research Units
United States
Zip Code
Park, Eun Chan; Rongo, Christopher (2018) RPM-1 and DLK-1 regulate pioneer axon outgrowth by controlling Wnt signaling. Development 145:
Silva, Malan; Morsci, Natalia; Nguyen, Ken C Q et al. (2017) Cell-Specific ?-Tubulin Isotype Regulates Ciliary Microtubule Ultrastructure, Intraflagellar Transport, and Extracellular Vesicle Biology. Curr Biol 27:968-980
Park, Eun Chan; Rongo, Christopher (2016) The p38 MAP kinase pathway modulates the hypoxia response and glutamate receptor trafficking in aging neurons. Elife 5:
Joshi, Kishore K; Matlack, Tarmie L; Rongo, Christopher (2016) Dopamine signaling promotes the xenobiotic stress response and protein homeostasis. EMBO J 35:1885-901
Zhang, Donglei; Dubey, Jyoti; Koushika, Sandhya P et al. (2016) RAB-6.1 and RAB-6.2 Promote Retrograde Transport in C. elegans. PLoS One 11:e0149314
Rongo, Christopher (2015) Better to burn out than it is to rust: coordinating cellular redox states during aging and stress. EMBO J 34:2310-1
Rongo, Christopher (2013) Going mobile: AMPA receptors move synapse to synapse in vivo. Neuron 80:1339-41
Ghose, Piya; Park, Eun Chan; Tabakin, Alexandra et al. (2013) Anoxia-reoxygenation regulates mitochondrial dynamics through the hypoxia response pathway, SKN-1/Nrf, and stomatin-like protein STL-1/SLP-2. PLoS Genet 9:e1004063
Toth, Marton Lorant; Melentijevic, Ilija; Shah, Leena et al. (2012) Neurite sprouting and synapse deterioration in the aging Caenorhabditis elegans nervous system. J Neurosci 32:8778-90
Park, Eun Chan; Ghose, Piya; Shao, Zhiyong et al. (2012) Hypoxia regulates glutamate receptor trafficking through an HIF-independent mechanism. EMBO J 31:1379-93

Showing the most recent 10 out of 12 publications